Literature DB >> 20535504

Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo.

Shinichi Esaki1, Fumi Goshima, Sachiyo Katsumi, Daisuke Watanabe, Noriyuki Ozaki, Shingo Murakami, Yukihiro Nishiyama.   

Abstract

We compared apoptosis induction in mice following three routes of infection. After intravenous infection, wild-type herpes simplex virus (HSV) types 1 and 2 and US3Delta mutants infected the adrenal gland and caused apoptosis. Corneal infection with wild-type virus resulted in apoptosis in a fraction of infected epithelium cells. Interestingly, many uninfected cells were apoptotic in the retina. Although neurons in the trigeminal ganglion were heavily infected, no apoptotic neurons were observed. Intracranial infection with wild-type virus resulted in HSV-infected cells inside the brain; however, most of the infected neurons escaped apoptosis. In contrast, infection with US3Delta and gamma(1)34.5Delta mutants caused apoptosis in infected neurons. Cleaved caspase-8 and p53 were detected in apoptotic cells in the adrenal gland and the brain; however, phospho-JNK was detected only in apoptotic cells of the brain. These results suggest that the activation of apoptotic signaling proteins differs depending on the host cell type and modulates the induction of apoptosis in HSV-infected cells.

Entities:  

Mesh:

Year:  2010        PMID: 20535504     DOI: 10.1007/s00705-010-0712-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Authors:  Lin Zhou; Jieliang Li; Xu Wang; Li Ye; Wei Hou; Jie Ho; He Li; Wenzhe Ho
Journal:  J Neurovirol       Date:  2011-04-16       Impact factor: 2.643

2.  Different modes of herpes simplex virus type 1 spread in brain and skin tissues.

Authors:  Yael Tsalenchuck; Tomer Tzur; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

Review 3.  Control of HSV-1 latency in human trigeminal ganglia--current overview.

Authors:  Kathrin Held; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

Review 4.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

5.  A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

Authors:  Ryuichi Kanai; Hiroaki Wakimoto; Robert L Martuza; Samuel D Rabkin
Journal:  Clin Cancer Res       Date:  2011-04-19       Impact factor: 12.531

6.  Latent herpes simplex virus 1 infection does not induce apoptosis in human trigeminal Ganglia.

Authors:  Susanne Himmelein; Anja Lindemann; Inga Sinicina; Michael Strupp; Thomas Brandt; Katharina Hüfner
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

7.  Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain.

Authors:  Yael Tsalenchuck; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2016-04-20       Impact factor: 2.643

8.  Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma.

Authors:  Shinichi Esaki; Samuel D Rabkin; Robert L Martuza; Hiroaki Wakimoto
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  A neuron-specific role for autophagy in antiviral defense against herpes simplex virus.

Authors:  Brian Yordy; Norifumi Iijima; Anita Huttner; David Leib; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

10.  Inhibition of Bim enhances replication of varicella-zoster virus and delays plaque formation in virus-infected cells.

Authors:  Xueqiao Liu; Jeffrey I Cohen
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.